Jaguar Health, Inc.
JAGX
$1.76
-$0.03-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.48% | -5.83% | 52.57% | 10.49% | 1.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.48% | -5.83% | 52.57% | 10.49% | 1.68% |
| Cost of Revenue | 23.42% | 19.77% | -18.92% | 5.25% | -13.03% |
| Gross Profit | 6.89% | -11.56% | 83.01% | 11.66% | 4.99% |
| SG&A Expenses | 23.23% | 26.89% | 23.22% | 15.60% | -2.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.77% | 10.12% | 22.98% | -10.60% | -7.98% |
| Operating Income | -11.25% | -14.68% | -13.51% | 17.36% | 11.17% |
| Income Before Tax | -9.68% | -13.11% | -9.94% | -26.78% | 21.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.68% | -13.11% | -9.94% | -26.78% | 21.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.50% | -7.04% | 125.90% | 32.54% | -3.55% |
| Net Income | -9.64% | -13.42% | -8.18% | -26.69% | 21.88% |
| EBIT | -11.25% | -14.68% | -13.51% | 17.36% | 11.17% |
| EBITDA | -11.54% | -15.92% | -14.89% | 18.05% | 11.17% |
| EPS Basic | -286.03% | 80.83% | 92.60% | 95.33% | 99.74% |
| Normalized Basic EPS | -217.78% | 83.10% | 92.36% | 96.84% | 99.74% |
| EPS Diluted | -286.03% | 80.83% | 92.60% | 95.33% | 99.74% |
| Normalized Diluted EPS | -217.78% | 83.10% | 92.36% | 96.84% | 99.74% |
| Average Basic Shares Outstanding | -71.60% | 491.69% | 1,361.04% | 2,615.94% | 30,179.66% |
| Average Diluted Shares Outstanding | -71.60% | 491.69% | 1,361.04% | 2,615.94% | 30,179.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |